Reducing Intimal Hyperplasia in Coronary Arteries with SIN-1
Author Information
Author(s): Harnek Jan, Zoucas Evita, de Sá Valéria Perez, Ekblad Eva, Arner Anders, Stenram Unne
Primary Institution: Skane University Hospital, Lunds University
Hypothesis
Does local delivery of the NO donor SIN-1 affect intimal hyperplasia after percutaneous transluminal coronary angioplasty (PTCA) via a cGMP-dependent pathway?
Conclusion
Local delivery of high concentrations of the NO donor SIN-1 for 5 minutes significantly inhibited injury-induced neointimal hyperplasia after PTCA.
Supporting Evidence
- SIN-1 treated arteries had significantly larger diameters compared to controls.
- Intimal hyperplasia was significantly reduced in SIN-1 treated segments.
- The favorable effects of SIN-1 were abolished by the guanylyl cyclase inhibitor ODQ.
- Restenosis index was significantly lower in SIN-1 treated arteries.
Takeaway
This study found that giving a special medicine called SIN-1 right after a heart procedure helps keep the arteries open and healthy.
Methodology
Porcine coronary arteries were treated with PTCA and then locally treated with SIN-1 or a combination of SIN-1 and a guanylate cyclase inhibitor, followed by evaluations at one and eight weeks.
Potential Biases
Potential bias in treatment randomization and animal model limitations.
Limitations
The study was conducted on pigs, which may not fully represent human responses.
Participant Demographics
Twenty-nine domestic pigs weighing approximately 21.5 kg.
Statistical Information
P-Value
p < 0.01
Statistical Significance
p < 0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website